HSV-mediated p55TNFSR reduces neuropathic pain induced by HIV gp120 in rats through CXCR4 activity

Gene Therapy

Volumn 21, Issue 3, 2014, Pages 328-336

  Huang, W ^a,b   Zheng, W ^a   Liu, S ^a   Zeng, W ^b   Levitt, R C ^a,c   Candiotti, K A ^a   Lubarsky, D A ^a   Hao, S ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

CXCR4; HIV pain; TNF

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; GLYCOPROTEIN GP 120; P55 TUMOR NECROSIS FACTOR SOLUBLE RECEPTOR; PLERIXAFOR; STROMAL CELL DERIVED FACTOR 1ALPHA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG; VIRUS VECTOR;

ALLODYNIA; ANIMAL EXPERIMENT; ARTICLE; BIOLOGICAL ACTIVITY; CONTROLLED STUDY; HERPES SIMPLEX VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; NEUROPATHIC PAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SCIATIC NERVE; SPINAL CORD DORSAL HORN; SPINAL GANGLION; UPREGULATION;

HUMAN IMMUNODEFICIENCY VIRUS; RATTUS; SIMPLEXVIRUS;

ANIMALS; CHEMOKINE CXCL12; GANGLIA, SPINAL; GENETIC THERAPY; HETEROCYCLIC COMPOUNDS; HIV ENVELOPE PROTEIN GP120; MALE; NEURALGIA; POSTERIOR HORN CELLS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CXCR4; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; SIMPLEXVIRUS; TUMOR NECROSIS FACTOR DECOY RECEPTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84896702822     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/gt.2013.90     Document Type: Article

References (74)

1. Theroux N, Phipps M, Zimmerman L, Relf MV. Neurological complications associated with HIV and AIDS: clinical implications for nursing. J Neurosci Nurs 2013; 45: 5-13.
2. Keswani SC, Pardo CA, Cherry CL, Hoke A, McArthur JC. HIV-associated sensory neuropathies. AIDS 2002; 16: 2105-2117. (Pubitemid 35387264)
3. Keswani SC, Jack C, Zhou C, Hoke A. Establishment of a rodent model of HIV-associated sensory neuropathy. J Neurosci 2006; 26: 10299-10304. (Pubitemid 44527423)
4. Gabbai AA, Castelo A, Oliveira AS. HIV peripheral neuropathy. Handb Clin Neurol 2013; 115: 515-529.
5. Cornblath DR, McArthur JC. Predominantly sensory neuropathy in patients with AIDS and AIDS-related complex. Neurology 1988; 38: 794-796.
6. Kamerman PR, Moss PJ, Weber J, Wallace VC, Rice AS, Huang W. Pathogenesis of HIV-associated sensory neuropathy: evidence from in vivo and in vitro experimental models. J Peripher Nerv Syst 2012; 17: 19-31.
7. Hao S. The molecular and pharmacological mechanisms of HIV-related neuropathic pain. Curr Neuropharmacol 2013; 11: 499-512.
8. Shi Y, Gelman BB, Lisinicchia JG, Tang SJ. Chronic-pain-associated astrocytic reaction in the spinal cord dorsal horn of human immunodeficiency virus-infected patients. J Neurosci 2012; 32: 10833-10840.
9. Hoke A, Morris M, Haughey NJ. GPI-1046 protects dorsal root ganglia from gp120-induced axonal injury by modulating store-operated calcium entry. J Peripher Nerv Syst 2009; 14: 27-35.
10. Herzberg U, Sagen J. Peripheral nerve exposure to HIV viral envelope protein gp120 induces neuropathic pain and spinal gliosis. J Neuroimmunol 2001; 116: 29-39. (Pubitemid 32322637)
11. Blackbeard J, Wallace VC, O'Dea KP, Hasnie F, Segerdahl A, Pheby T et al. The correlation between pain-related behaviour and spinal microgliosis in four distinct models of peripheral neuropathy. Eur J Pain 2012; 16: 1357-1367.
12. Wallace VC, Blackbeard J, Segerdahl AR, Hasnie F, Pheby T, McMahon SB et al. Characterization of rodent models of HIV-gp120 and anti-retroviral- associated neuropathic pain. Brain 2007; 130(Pt 10): 2688-2702. (Pubitemid 47511710)
13. Wallace VC, Blackbeard J, Pheby T, Segerdahl AR, Davies M, Hasnie F et al. Pharmacological, behavioural and mechanistic analysis of HIV-1 gp120 induced painful neuropathy. Pain 2007; 133: 47-63. (Pubitemid 350138309)
14. Wallace VC, Segerdahl AR, Blackbeard J, Pheby T, Rice AS. Anxiety-like behaviour is attenuated by gabapentin, morphine and diazepam in a rodent model of HIV anti-retroviral-associated neuropathic pain. Neurosci Lett 2008; 448: 153-156.
15. Zheng W, Ouyang H, Zheng X, Liu S, Mata M, Fink DJ et al. Glial TNFalpha in the spinal cord regulates neuropathic pain induced by HIV gp120 application in rats. Mol Pain 2011; 7: 40.
16. Raghavendra V, Rutkowski MD, DeLeo JA. The role of spinal neuroimmune activation in morphine tolerance/hyperalgesia in neuropathic and sham-operated rats. J Neurosci 2002; 22: 9980-9989. (Pubitemid 35332883)
17. Watkins LR, Milligan ED, Maier SF. Glial activation: a driving force for pathological pain. Trends Neurosci 2001; 24: 450-455. (Pubitemid 32695356)
18. DeLeo JA, Tanga FY, Tawfik VL. Neuroimmune activation and neuroinflammation in chronic pain and opioid tolerance/hyperalgesia. Neuroscientist 2004; 10: 40-52. (Pubitemid 38112699)
19. Leung L, Cahill CM. TNF-alpha and neuropathic pain-a review. J Neuroinflammation 2010; 7: 27.
20. Gao YJ, Zhang L, Ji RR. Spinal injection of TNF-alpha-activated astrocytes produces persistent pain symptom mechanical allodynia by releasing monocyte chemoattractant protein-1. Glia 2010; 58: 1871-1880.
21. Mocchetti I, Campbell LA, Harry GJ, Avdoshina V. When human immunodeficiency virus meets chemokines and microglia: neuroprotection or neurodegeneration? J Neuroimmune Pharmacol 2012; 8: 14
22. Keswani SC, Polley M, Pardo CA, Griffin JW, McArthur JC, Hoke A. Schwann cell chemokine receptors mediate HIV-1 gp120 toxicity to sensory neurons. Ann Neurol 2003; 54: 287-296. (Pubitemid 37072031)
23. Catani MV, Corasaniti MT, Navarra M, Nistico G, Finazzi-Agro A, Melino G. gp120 induces cell death in human neuroblastoma cells through the CXCR4 and CCR5 chemokine receptors. J Neurochem 2000; 74: 2373-2379. (Pubitemid 30314213)
24. Bhangoo SK, Ren D, Miller RJ, Chan DM, Ripsch MS, Weiss C et al. CXCR4 chemokine receptor signaling mediates pain hypersensitivity in association with antiretroviral toxic neuropathy. Brain Behav Immun 2007; 21: 581-591. (Pubitemid 46829778)
25. Wilson NM, Jung H, Ripsch MS, Miller RJ, White FA. CXCR4 signaling mediates morphine-induced tactile hyperalgesia. Brain Behav Immun 2011; 25: 565-573.
26. Homma Y, Brull SJ, Zhang JM. A comparison of chronic pain behavior following local application of tumor necrosis factor alpha to the normal and mechanically compressed lumbar ganglia in the rat. Pain 2002; 95: 239-246. (Pubitemid 34142647)
27. Zhao C, Lu X, Bu X, Zhang N, Wang W. Involvement of tumor necrosis factor-alpha in the upregulation of CXCR4 expression in gastric cancer induced by Helicobacter pylori. BMC Cancer 2010; 10: 419.
28. Wilson SP, Yeomans DC, Bender MA, Lu Y, Goins WF, Glorioso JC. Antihyperalgesic effects of infection with a preproenkephalin-encoding herpes virus. Proc Natl Acad Sci USA 1999; 96: 3211-3216. (Pubitemid 29148870)
29. Goss JR, Mata M, Goins WF, Wu HH, Glorioso JC, Fink DJ. Antinociceptive effect of a genomic herpes simplex virus-based vector expressing human proenkephalin in rat dorsal root ganglion. Gene Therapy 2001; 8: 551-556. (Pubitemid 32409530)
30. Braz J, Beaufour C, Coutaux A, Epstein AL, Cesselin F, Hamon M et al. Therapeutic efficacy in experimental polyarthritis of viral-driven enkephalin overproduction in sensory neurons. J Neurosci 2001; 21: 7881-7888. (Pubitemid 32952747)
31. Antunes bras J, Becker C, Bourgoin S, Lombard M, Cesselin F, Hamon M et al. Met-enkephalin is preferentially transported into the peripheral processes of primary afferent fibres in both control and HSV1-driven proenkephalin A overexpressing rats. Neuroscience 2001; 103: 1073-1083. (Pubitemid 32289317)
32. Yokoyama H, Sasaki K, Franks ME, Goins WF, Goss JR, de Groat WC et al. Gene therapy for bladder overactivity and nociception with herpes simplex virus vectors expressing preproenkephalin. Hum Gene Ther 2009; 20: 63-71.
33. Hao S, Mata M, Glorioso JC, Fink DJ. Gene transfer to interfere with TNFalpha signaling in neuropathic pain. Gene Therapy 2007; 14: 1010-1016. (Pubitemid 46965270)
34. Sun J, Liu S, Mata M, Fink DJ, Hao S. Transgene-mediated expression of tumor necrosis factor soluble receptor attenuates morphine tolerance in rats. Gene Therapy 2012; 19: 101-108.
35. Peng XM, Zhou ZG, Glorioso JC, Fink DJ, Mata M. Tumor necrosis factor-alpha contributes to below-level neuropathic pain after spinal cord injury. Ann Neurol 2006; 59: 843-851. (Pubitemid 43673162)
36. Huang W, Zheng W, Ouyang H, Yi H, Liu S, Zeng W et al. Mechanical allodynia induced by nucleoside reverse transcriptase inhibitor is suppressed by p55TNFSR mediated by HSV through SDF1a/CXCR4 system in rats. Anesth Analg 2013 (in press).
37. Fink DJ, Wechuck J, Mata M, Glorioso JC, Goss J, Krisky D et al. Gene therapy for pain: results of a phase I clinical trial. Ann Neurol 2011; 70: 207-212.
38. Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 1994; 53: 55-63. (Pubitemid 24238751)
39. Dixon WJ. Efficient analysis of experimental observations. Annu Rev Pharmacol Toxicol 1980; 20: 441-462.
40. Oh SB, Tran PB, Gillard SE, Hurley RW, Hammond DL, Miller RJ. Chemokines and glycoprotein120 produce pain hypersensitivity by directly exciting primary nociceptive neurons. J Neurosci 2001; 21: 5027-5035. (Pubitemid 32622928)
41. Dubovy P, Klusakova I, Svizenska I, Brazda V. Spatio-temporal changes of SDF1 and its CXCR4 receptor in the dorsal root ganglia following unilateral sciatic nerve injury as a model of neuropathic pain. Histochem Cell Biol 2010; 133: 323-337.
42. Hao S, Wolfe D, Glorioso JC, Mata M, Fink DJ. Effects of transgene-mediated endomorphin-2 in inflammatory pain. Eur J Pain 2009; 13: 380-386.
43. Yaksh TL, Rudy TA. Analgesia mediated by a direct spinal action of narcotics. Science 1976; 192: 1357-1358.
44. Polydefkis M, Yiannoutsos CT, Cohen BA, Hollander H, Schifitto G, Clifford DB et al. Reduced intraepidermal nerve fiber density in HIV-associated sensory neuropathy. Neurology 2002; 58: 115-119. (Pubitemid 34041947)
45. Martin C, Solders G, Sonnerborg A, Hansson P. Painful and non-painful neuropathy in HIV-infected patients: an analysis of somatosensory nerve function. Eur J Pain 2003; 7: 23-31. (Pubitemid 36149692)
46. Roth MD, Whittaker KM, Choi R, Tashkin DP, Baldwin GC. Cocaine and sigma-1 receptors modulate HIV infection, chemokine receptors, and the HPA axis in the huPBL-SCID model. J Leukoc Biol 2005; 78: 1198-1203. (Pubitemid 41779224)
47. Berman JW, Carson MJ, Chang L, Cox BM, Fox HS, Gonzalez RG et al. NeuroAIDS, drug abuse, and inflammation: building collaborative research activities. J Neuroimmune Pharmacol 2006; 1: 351-399. (Pubitemid 44786672)
48. Mahajan SD, Schwartz SA, Nair MP. Immunological assays for chemokine detection in in-vitro culture of CNS cells. Biol Proced Online 2003; 5: 90-102. (Pubitemid 38097503)
49. Williams KC, Burdo TH. HIV and SIV infection: the role of cellular restriction and immune responses in viral replication and pathogenesis. APMIS 2009; 117: 400-412.
50. Gelman BB, Spencer JA, Holzer 3rd CE, Soukup VM. Abnormal striatal dopaminergic synapses in National NeuroAIDS Tissue Consortium subjects with HIV encephalitis. J Neuroimmune Pharmacol 2006; 1: 410-420. (Pubitemid 44786674)
51. Jernigan TL, Gamst AC, Archibald SL, Fennema-Notestine C, Mindt MR, Marcotte TD et al. Effects of methamphetamine dependence and HIV infection on cerebral morphology. Am J Psychiatry 2005; 162: 1461-1472. (Pubitemid 41105560)
52. Meeker RB. Feline immunodeficiency virus neuropathogenesis: from cats to calcium. J Neuroimmune Pharmacol 2007; 2: 154-170.
53. Kaul M, Lipton SA. Chemokines and activated macrophages in HIV gp120-induced neuronal apoptosis. Proc Natl Acad Sci USA 1999; 96: 8212-8216. (Pubitemid 29328434)
54. Kaul M, Garden GA, Lipton SA. Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 2001; 410: 988-994. (Pubitemid 32335850)
55. Ghafouri M, Amini S, Khalili K, Sawaya BE. HIV-1 associated dementia: symptoms and causes. Retrovirology 2006; 3: 28.
56. Nath A, Hauser KF, Wojna V, Booze RM, Maragos W, Prendergast M et al. Molecular basis for interactions of HIV and drugs of abuse. J Acquir Immune Defic Syndr 2002; 31(Suppl 2): S62-S69. (Pubitemid 35190560)
57. Podhaizer EM, Zou S, Fitting S, Samano KL, El-Hage N, Knapp PE et al. Morphine and gp120 toxic interactions in striatal neurons are dependent on HIV-1 strain. J Neuroimmune Pharmacol 2012; 7: 877-891.
58. Grimaldi LM, Martino GV, Franciotta DM, Brustia R, Castagna A, Pristera R et al. Elevated alpha-tumor necrosis factor levels in spinal fluid from HIV-1-infected patients with central nervous system involvement. Ann Neurol 1991; 29: 21-25.
59. Mastroianni CM, Paoletti F, Valenti C, Vullo V, Jirillo E, Delia S. Tumour necrosis factor (TNF-alpha) and neurological disorders in HIV infection. J Neurol Neurosurg Psychiatry 1992; 55: 219-221.
60. Perrella O, Carrieri PB, Guarnaccia D, Soscia M. Cerebrospinal fluid cytokines in AIDS dementia complex. J Neurol 1992; 239: 387-388.
61. Ciardi M, Sharief MK, Thompson EJ, Salotti A, Vullo V, Sorice F et al. High cerebrospinal fluid and serum levels of tumor necrosis factor-alpha in asymptomatic HIV-1 seropositive individuals. Correlation with interleukin-2 and soluble IL-2 receptor. J Neurol Sci 1994; 125: 175-179. (Pubitemid 24275314)
62. Tyor WR, Glass JD, Griffin JW, Becker PS, McArthur JC, Bezman L et al. Cytokine expression in the brain during the acquired immunodeficiency syndrome. Ann Neurol 1992; 31: 349-360.
63. de Larranaga GF, Petroni A, Deluchi G, Alonso BS, Benetucci JA. Viral load and disease progression as responsible for endothelial activation and/or injury in human immunodeficiency virus-1-infected patients. Blood Coagul Fibrinolysis 2003; 14: 15-18. (Pubitemid 36206717)
64. Achim CL, Heyes MP, Wiley CA. Quantitation of human immunodeficiency virus, immune activation factors, and quinolinic acid in AIDS brains. J Clin Invest 1993; 91: 2769-2775. (Pubitemid 23182534)
65. An SF, Ciardi A, Giometto B, Scaravilli T, Gray F, Scaravilli F. Investigation on the expression of major histocompatibility complex class II and cytokines and detection of HIV-1 DNA within brains of asymptomatic and symptomatic HIV-1-positive patients. Acta Neuropathol 1996; 91: 494-503. (Pubitemid 26133661)
66. Vitkovic L, da Cunha A, Tyor WR. Cytokine expression and pathogenesis in AIDS brain. Res Publ Assoc Res Nerv Ment Dis 1994; 72: 203-222.
67. Dorsey SG, Morton PG. HIV peripheral neuropathy: pathophysiology and clinical implications. AACN Clin Issues 2006; 17: 30-36.
68. Kitano K, Rivas CI, Baldwin GC, Vera JC, Golde DW. Tumor necrosis factor-dependent production of human immunodeficiency virus 1 in chronically infected HL-60 cells. Blood 1993; 82: 2742-2748. (Pubitemid 23318080)
69. Williams R, Dhillon NK, Hegde ST, Yao H, Peng F, Callen S et al. Proinflammatory cytokines and HIV-1 synergistically enhance CXCL10 expression in human astrocytes. Glia 2009; 57: 734-743.
70. Sui Z, Sniderhan LF, Schifitto G, Phipps RP, Gelbard HA, Dewhurst S et al. Functional synergy between CD40 ligand and HIV-1 Tat contributes to inflammation: implications in HIV type 1 dementia. J Immunol 2007; 178: 3226-3236. (Pubitemid 46333205)
71. Milligan ED, O'Connor KA, Nguyen KT, Armstrong CB, Twining C, Gaykema RP et al. Intrathecal HIV-1 envelope glycoprotein gp120 induces enhanced pain states mediated by spinal cord proinflammatory cytokines. J Neurosci 2001; 21: 2808-2819. (Pubitemid 32298222)
72. Miller RJ, Jung H, Bhangoo SK, White FA. Cytokine and chemokine regulation of sensory neuron function. Handb Exp Pharmacol 2009; 194: 417-449.
73. Hesselgesser J, Halks-Miller M, DelVecchio V, Peiper SC, Hoxie J, Kolson DL et al. CD4-independent association between HIV-1 gp120 and CXCR4: functional chemokine receptors are expressed in human neurons. Curr Biol 1997; 7: 112-121. (Pubitemid 27155620)
74. Bhangoo SK, Ripsch MS, Buchanan DJ, Miller RJ, White FA. Increased chemokine signaling in a model of HIV1-associated peripheral neuropathy. Mol Pain 2009; 5: 48.